Head to Head Stocks: ABIOMED, Inc. (NASDAQ:ABMD), Hi-Crush Partners LP (NYSE:HCLP)

earning reaction history, nasdaq, nyse

ABIOMED, Inc. (NASDAQ:ABMD)

ABIOMED, Inc. (NASDAQ:ABMD) closed at $265.68 on the last trading session with an increase of 0.02%, whereas, it previously closed at $265.64. The company has a market capitalization of $11.55 Billion. The company traded shares of 257240 on the trading day while its three month average volume stands at 528.84 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of ABIOMED, Inc. (NASDAQ:ABMD) produced diluted EPS of 4.43. The EPS estimate for next year as estimated by analysts is at 4.83 while EPS for next quarter is estimated at 0.29. Earnings per Share growth for this year is reported at -21, while the analysts estimated the EPS growth for next year at 4.83% and Earnings growth for next 5 years stands at 24% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 10.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of ABIOMED, Inc. (NASDAQ:ABMD) is at 60 while the forward p/e is at 54.97. The P/S or Price to Sales ratio of ABIOMED, Inc. (NASDAQ:ABMD) stands at 13.74 and Price to Book or P/B for the most recent quarter stands at 11.23. The Price to Free Cash Flow ratio or P/FCF is reported at 42.65. The quick ratio and the current ratio of ABIOMED, Inc. (NASDAQ:ABMD) are reported at 4.1 and 4.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for ABIOMED, Inc. (NASDAQ:ABMD) stands at 17.4, 19.8 and 17.9 respectively

The trailing twelve month Revenue of ABIOMED, Inc. (NASDAQ:ABMD) is reported at 840.9 Million with income of 203 Million. The outstanding shares of ABIOMED, Inc. (NASDAQ:ABMD) are 45.04 Million. The institutional Ownership of the shares of 98.2 stands at 0.80%, this figure is decreased -3.2 in the last six months. The insider ownership for the shares of ABIOMED, Inc. (NASDAQ:ABMD) is ticked at 1.4%, the figure is plummeted -3.72% in the last six months.

Some other important financial aspects to be discussed here for ABIOMED, Inc. (NASDAQ:ABMD) is the Mean Target Price estimated by the analysts which stands at 214.4. The 52 week high of ABIOMED, Inc. (NASDAQ:ABMD) is placed at 285.77 and 52 week low is standing at 119.01.

Performance wise the shares of ABIOMED, Inc. (NASDAQ:ABMD) rose up 4.1% for the week, it also rise 8.17% for the monthly performance, while for the quarter it went down 70.01%. The shares increase 48.68% for the half year and flew up for the Year-To-Date performance. The shares of ABIOMED, Inc. (NASDAQ:ABMD) grew 3.86% for the yearly performance.

Hi-Crush Partners LP (NYSE:HCLP)